FINWIRES · TerminalLIVE
FINWIRES

Jardine Matheson Acquires Australian Diagnostic Imaging Company I-Med Radiology for AU$3.4 Billion

By

Jardine Matheson (SGX:J36) agreed to fully acquire Australia-based I-Med Radiology Network from funds advised by Permira for AU$3.4 billion, according to a Monday filing with the Singapore Exchange.

The acquisition includes I-Med's minority stake in Harrison.ai, which develops AI radiology products.

I-Med operates 215 diagnostic imaging clinics across Australia and New Zealand and performs over 7 million procedures annually.

The investment is part of the company's strategy to focus on high-quality businesses across the Asia-Pacific region, Jardine Matheson said.

Shares of the Singapore-listed conglomerate rose nearly 2% in recent trade.

Related Articles

Asia

BHP Group Shares Gain as Coking Coal Price Spikes After Explosion at Chinese Mine

BHP Group (ASX:BHP) shares gained more than 1% in recent Monday trade as the price of coking coal spiked following a Friday explosion at a Chinese coal mine.Chinese coking coal futures increased by nearly 8% to hit their daily limit after the blast at the privately owned Liushenyu mine, which media reports described as China's deadliest mining accident in more than a decade.The incident left at least 82 people dead and will "almost certainly trigger widespread safety inspections that could affect China's much larger supplies of thermal coal, used in power generation," Bloomberg reported.The ⁠most active coking coal contract on ​the Dalian Commodity ​Exchange ⁠jumped 8% to the equivalent of about $186.76 per metric ton, Reuters reported.

$ASX:BHP
Asia

Colgate-Palmolive (India)'s Net Profit Declines in Fiscal Q4

Colgate-Palmolive (India)'s (NSE:COLPAL, BOM:500830) net profit declined to 3.53 billion Indian rupees in the fiscal fourth quarter ended March 31, from 3.55 billion rupees a year ago.Earnings per share contracted to 12.99 rupees from 13.05 rupees a year earlier, the personal care products company said in a filing to the Indian bourses on Friday.Revenue from operations in fiscal Q4, however, increased to 15.8 billion rupees from 14.5 billion rupees a year ago.The company's board declared a second interim dividend of 24 rupees per equity share of 1 rupee each for the financial year 2025-26.

$BOM:500830$NSE:COLPAL
Asia

Encounter Resources Makes 'Promising Start to Exploration' at Western Australia Copper Prospect, Euroz Hartleys Says

Encounter Resources (ASX:ENR) delivered "strong metallurgical test work results" from its Aileron project and has made a "promising start to exploration" at its Elsa prospect, both located in Western Australia, Euroz Hartleys said in a May 22 note.Initial metallurgical test work from the Green deposit in Aileron achieved niobium recoveries of 51% to 53% from head-grade feeds, while generating concentrate grades of up to 57% niobium pentoxide following refining, the investment firm said.The results show that "standard beneficiation and refining methods can be effectively applied, and importantly, the flowsheet is comparable to those used in existing niobium operations, reducing future development risks," Euroz Hartleys said.Meanwhile, first assays from ongoing reverse circulation drilling at the Elsa prospect intersected a new copper zone with 16 meters at 0.3% copper from 58 meters. Although the grades are modest, the result is still "highly encouraging at this early stage" and supports the presence of a broader system, the equity research firm said.Euroz Hartleys maintained a speculative buy rating on Encounter Resources with a price target of AU$0.85 per share.The company's shares gained 2% in recent Monday trade.

$ASX:ENR